Skip to content
OpenCapital
Get started

Acumen Pharmaceuticals, Inc. ABOS Q1 2026 earnings

Reported May 12, 2026 · Before market open

Diluted EPS-$0.33Beat by $0.07
EPS estimate-$0.40

Next report

Aug 11, 2026 (in a month)
EPS estimate-$0.39

Versus estimates

Diluted EPS

Q1 2026-$0.33Beat by $0.07
Q4 2025-$0.41Beat by $0.09Q3 2025-$0.44Beat by $0.19Q2 2025-$0.68Miss by $0.14Q1 2025-$0.48Beat by $0.08Q4 2024-$0.62Miss by $0.15

Ask the moment Acumen Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Acumen Pharmaceuticals, Inc. report Q1 2026 earnings?
Acumen Pharmaceuticals, Inc. (ABOS) reported Q1 2026 earnings on May 12, 2026 before market open.
What were Acumen Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
Acumen Pharmaceuticals, Inc. reported diluted EPS of $-0.33 for Q1 2026.
Did Acumen Pharmaceuticals, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.40 by $0.07.
How did Acumen Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 31.2% from $-0.48.
Where can I find Acumen Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-033868) and the 10-Q periodic report (0001628280-26-034204) directly on SEC EDGAR. The filing index links above go to sec.gov.